Tumour Trace boss wants to make early cancer screening “available for everybody everywhere at a cost everyone can afford”

The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system

More From BioPortfolio on "Tumour Trace boss wants to make early cancer screening “available for everybody everywhere at a cost everyone can afford”"